 Travere Therapeutics, Inc. NASDAQ:TVTX Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Company Participants Chris Cline Senior Vice President-Investor Relations Eric Dube Chief Executive Officer Jula Inrig Chief Medical Officer Peter Heerma Chief Commercial Officer Laura Clague Chief Financial Officer Bill Rote Senior Vice President-Research Development Conference Call Participants Carter Gould Barclays Mary Kate Davis Bank of America Liisa Bayko Evercore ISI Maury Raycroft Jefferies Tim Lugo William Blair Laura Chico Wedbush Securities Ed Arce H.C. Wainwright and Company Operator Good day, and welcome to the Travere Therapeutics Conference Call. 